Pharmacokinetics of tramadol and its major metabolites following rectal and intravenous administration in dogs

New Zealand Veterinary Journal

Volumn 57, Issue 3, 2009, Pages 146-152

  Giorgi, M ^a   Del Carlo, S ^b   Saccomanni, G ^b   Lebkowska Wieruszewska, B ^c   Kowalski, C J ^c  

^a Department of Veterinary Clinics ^*  (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Bioavailability; Intravenous; Metabolites; Suppository; Tramadol

Indexed keywords

DRUG DERIVATIVE; NARCOTIC ANALGESIC AGENT; O NORTRAMADOL; O-DEMETHYLTRAMADOL; TRAMADOL;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOAVAILABILITY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOG; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SUPPOSITORY;

ADMINISTRATION, RECTAL; ANALGESICS, OPIOID; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOGS; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; SUPPOSITORIES; TRAMADOL;

CANIS FAMILIARIS;

EID: 68549118706     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.2009.36894     Document Type: Article

References (32)

1. Barth H, Giertz H, Schmal A, Lorenz W. Anaphylactoid reactions and histamine release do not occur after application of the opioid tramadol. Agents and Actions 20, 310–3, 1987
2. de Sousa AB, Santos AC, Schramm SG, Porta V Gorniak SL, Florio JC, de Souza Spinosa H. Pharmacokinetics of tramadol and O-desmethyltramadol in goats after intravenous and oral administration. Journal of Veterinary Pharmacology and Therapeutics 31, 45–51, 2008
3. Elghazali M, Barezaik IM, Abdel Hadi AA, Eltayeb FM, Al Masri J, Wasfi IA. The pharmacokinetics, metabolism and urinary detection time of tramadol in camels. Veterinary Journal 178, 272–7, 2008
4. Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Swedish Pharmaceutical Press, Stockholm, Sweden, 2002
5. Gillen C, Haurand M, Kobelt DJ, Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn-Schmiedeberg’s Archives of Pharmacology 362, 116–21, 2000
6. Giorgi M, Saccomanni G, Daniello MR, Manera C, Soldani G, Ferrarini PL, Giusiani M. In vitro metabolism of tramadol in horses: preliminary data. Journal of Veterinary Pharmacology and Therapeutics 29, 124, 2006
7. Giorgi M, Soldani G, Manera C, Ferrarini PL, Sgorbini M, Saccomanni G. Pharmacokinetics of tramadol and its metabolites M1, M2 and M5 in horses following intravenous, immediate release (fasted/fed) and sustained release single dose administration. Journal of Equine Veterinary Science 27, 481–8, 2007
8. Giorgi M, Del Carlo S, Sgorbini M, Saccomanni G. Pharmacokinetics of tramadol and its metabolites M1, M2 and M5 in donkeys following intravenous and oral immediate release single dose administration. Journal of Equine Veterinary Science (In press), 2009 a
9. Giorgi M, Saccomanni G, Lebkowska-Wieruszewska B, Kowalski C. Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study. Veterinary Journal 180, 253–5, 2009 b
10. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clinical Pharmacokinetics 43, 879–923, 2004
11. Grond S, Meuser T, Uragg H, Stahlberg HJ, Lehmann KA. Serum concentrations of tramadol enantiomers during patient-controlled analgesia. British Journal of Clinical Pharmacology 48, 254–7, 1999
12. Gupta PJ. Suppositories in anal disorders: a review. European Review for Medical and Pharmacological Sciences 11, 165–70, 2007
13. Hojo T, Ohno R, Shimoda M, Kokue E. Enzyme and plasma protein induction by multiple oral administrations of phenobarbital at a therapeutic dosage regimen in dogs. Journal of Veterinary Pharmacology and Therapeutics 25, 121–7, 2002
14. Kogel B, Englberger W Hennies HH, Friderichs E. Involvement of metabolites in the analgesic action of tramadol. Proceedings of the 9th World Congress of Pain. P 523, 1999
15. KuKanich B, Papich MG. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs. Journal of Veterinary Pharmacology and Therapeutics 27, 239–46, 2004
16. Lehmann KA, Kratzenberg U, Schroeder-Bark B, Horrichs-Haermeyer G. Postoperative patient-controlled analgesia with tramadol: analgesic efficacy and minimum effective concentrations. Clinical Journal of Pain 6, 212–20, 1990
17. Lintz W Erlain S, Frankus E, Uragg H. Biotransformation of tramadol in man and animal. Arzneimittel-Forschung 31, 1932–43, 1981
18. Lintz W, Barth H, Osterloh G, Schmidt-Bothelt E. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories. Arzneimittel-Forschung 48, 889–99, 1998
19. Malonne H, Sonet B, Streel B, Lebrun S, De Niet S, Sereno A, Vanderbist F. Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol. British Journal of Clinical Pharmacology 57, 270–8, 2004
20. Nakamura A, Yamamoto Y, Tasaki T, Sugimoto C, Masuda M, Kazusaka A, Fujita S. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody. Drug Metabolism and Disposition 23, 1268–73, 1995
21. Nosal’ova G, Strapkova A, Korpas J. Relationship between the antitussic and analgesic activity of substances. Acta Physiologica Hungarica 77, 173–8, 1991
22. Pypendop BH, Ilkiw JE. Pharmacokinetics of tramadol, and its metabolite O-desmethyl-tramadol, in cats. Journal of Veterinary Pharmacology and Therapeutics 31, 52–9, 2008
23. Raffa RB, Friderichs E, Reimann W Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. Journal of Pharmacology and Experimental Therapeutics 260, 275–85, 1992
24. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, Selve N. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. Journal of Pharmacology and Experimental Therapeutics 267, 331–40, 1993
25. Schwartz S, Pateman T. Preclinical pharmacokinetics. In: Evans G (ed). Handbook of Bioanalysis and Drug Metabolism. Pp 113–31. CRC Press LLC, Boca Raton FL, USA, 2004
26. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 60, 139–76, 2000
27. Shilo Y, Britzi M, Eytan B, Lifschitz T, Soback S, Steinman A. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration. Journal ofVeterinary Pharmacology and Therapeutics 31, 60–5, 2008
28. Subrahmanyam V, Renwick AB, Walters DG, Young PJ, Price RJ, Tonelli AP, Lake BG. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metabolism and Disposition 29, 1146–55, 2001
29. Warren PM, Taylor JH, Nicholson KE, Wraith PK, Drummond GB. Influence of tramadol on the ventilatory response to hypoxia in humans. British Journal of Anaesthesia 85, 211–6, 2000
30. Wilder-Smith CH, Bettiga A. The analgesic tramadol has minimal effect on gastrointestinal motor function. British Journal of Clinical Pharmacology 43, 71-5, 1997
31. Yamaoka K, Terumichi N, Uno T. Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics 6, 165–75, 1978
32. Zwaveling J, Bubbers S, van Meurs AH, Schoemaker RC, van Heel IR, Vermeij P, Burggraaf J. Pharmacokinetics of rectal tramadol in postoperative paediatric patients. British Journal of Anaesthesia 93, 224–7, 2004